Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Making claims: functional foods for managing appetite and weight

Subjects

Abstract

Functional food products promote claims such as 'freedom from hunger' and 'feel fuller for longer'. A legislative framework has been established by the European Food Safety Authority to evaluate the validity of such claims: a claim must be substantiated by scientific evidence and should be clearly understood by consumers. Since consumed foods influence appetite by means of a system of physiological satiety signals, functional foods could in principle act by increasing the potency and/or duration of these signals. Importantly, what constitutes a useful action: a reduction in hunger, an increase in fullness, a change in food intake at a meal, an adjustment in daily energy balance or a reduction in body weight? Any claim should not go beyond the scientific evidence of an effect, and methods exist to scientifically evaluate claims. The wording of a claim is, therefore, critical. The difference between a proof of concept and a guarantee of success is an important point that needs to be conveyed to the consumer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Satiety cascade showing the relationship between satiation and satiety, and some mediating psychological and physiological processes.

Similar content being viewed by others

References

  1. Government Office for Science. Foresight: Tackling Obesities: Future choices—Project report [online]. (2007).

  2. European Food Safety Authority (EFSA). The regulation 1924/2006 on food and health claims [online]. (2006).

  3. Pittler, M. H. & Ernst, E. Dietary supplements for body-weight reduction: a systematic review. Am. J. Clin. Nutr. 72, 529–536 (2004).

    Article  Google Scholar 

  4. Lean, M. E. J. Trading regulations and health foods. BMJ 337, a2408 (2008).

    Article  CAS  Google Scholar 

  5. Asp, N. G. & Contor, L. Process for the Assessment of Scientific Support for Claims on Food (PASSCLAIM): overall introduction. Eur. J. Nutr. 42 (Suppl. 1), 13–15 (2003).

    Google Scholar 

  6. Blundell, J. E. Pharmacological approaches to appetite suppression. Trends Pharmacol. Sci. 12, 147–157 (1991).

    Article  CAS  Google Scholar 

  7. Blundell, J. E. in Eating Disorders and Obesity: a Comprehensive Textbook Ch. 8 (eds Fairburn, C. G. & Brownell, K. D.) 43–49 (Guilford Press, New York, 2002).

    Google Scholar 

  8. Blundell, J. E., Rogers, P. J. & Hill, A. J. in Food Acceptance and Nutrition (eds Solms, J., Booth, D. A., Pangbourne, R. M. & Raunhardt, O.) 205–219 (Academic Press, London, 1987).

    Google Scholar 

  9. Blundell, J. E., King, N. A. & Halford, J. C. G. in Obesity and Functional Foods in Europe (eds Palou, A., Bonet, M. L. & Serra, F.) 302–316 (COST Action 918, European Communities, Office for official publications of the European Communities, Luxembourg, 2002).

    Google Scholar 

  10. Halford, J. C. G. & Blundell, J. E. Pharmacology of appetite suppression. Prog. Drug Res. 54, 25–58 (2000).

    Article  CAS  Google Scholar 

  11. Cummings, D. E. Ghrelin and the short- and long-term regulations of appetite and body weight. Physiol. Behav. 71, 71–84 (2006).

    Article  Google Scholar 

  12. Morton, G. J. & Schwartz, M. W. The NPY/AgRP neuron and energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25 (Suppl. 5), S56–S62 (2001).

    Article  CAS  Google Scholar 

  13. De Graaf, C., Blom, W. A. M., Smeets, P. A. M., Stafleu, A. & Hendriks, H. F. J. Biomarkers of satiation and satiety. Am. J. Clin. Nutr. 79, 946–961 (2004).

    Article  CAS  Google Scholar 

  14. Blom, W. A. et al. Effect of a high-protein breakfast on the postprandial ghrelin response. Am. J. Clin. Nutr. 83, 211–220 (2006).

    Article  CAS  Google Scholar 

  15. Tataranni, P. A. et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc. Natl Acad. Sci. USA 96, 4569–4574 (1999).

    Article  CAS  Google Scholar 

  16. Small, D. M., Zatorre, R. J., Dagher, A., Evans, A. C. & Jones-Gotman, M. Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 124, 1720–1733 (2001).

    Article  CAS  Google Scholar 

  17. Ello-Martin, J. A., Roe, L. S., Ledikwe, J. H., Beach, A. M. & Rolls, B. J. Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am. J. Clin. Nutr. 85, 1465–1477 (2007).

    Article  CAS  Google Scholar 

  18. Hochstenbach-Waelen, A., Veldhorst, M. A. B., Nieuwenhuizen, A. G., Westerterp-Plantenga, M. S. & Westerterp, K. R. Comparison of 2 diets with either 25% or 10% of energy as casein on energy expenditure, substrate balance, and appetite profile. Am. J. Clin. Nutr. 89, 831–838 (2009).

    Article  CAS  Google Scholar 

  19. Rolls, B. J., Shide, D. J., Thiorwart, M. L. & Ulbrecht, J. S. Sibutramine reduces food intake in non-dieting women with obesity. Obes. Res. 6, 1–11 (1998).

    Article  CAS  Google Scholar 

  20. Blundell, J. E. et al. Effect of rimonabant on energy intake, motivation to eat and body weight with or without hypocaloric diet: the REBA study. Obesity Rev. 7, 104 (2006).

    Google Scholar 

  21. NutraIngredients.com. The Short-sightedness of Clinical Trials. Interview with Jeffrey Blumberg [online]. (2008).

  22. Diepvens, K., Soenen, S., Steijns, J., Arnold, M. & Westerterp-Plantenga, M. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management. Int. J. Obes. 31, 942–949 (2007).

    Article  CAS  Google Scholar 

  23. Blundell, J. E. et al. The fat paradox: fat-induced satiety signals versus high fat overconsumption. Int. J. Obes. Relat. Metab. Disord. 19, 832–835 (1995).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

J. Blundell is an expert consultant to the NDA Panel of the European Food Safety Authority (EFSA), a Scientific Governor of the British Nutrition Foundation, and Treasurer and Trustee of the European Association for the Study of Obesity. He is also an advisor/consultant to industrial companies in the food and pharmaceutical sectors (Consultant: Merck, Amylin, Covance, Barilla, Danone; Speakers bureau: Kellogg's, Fonterra; Grant/research support: National Starch, Coca-Cola, Sanofi-aventis, Unilever).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blundell, J. Making claims: functional foods for managing appetite and weight. Nat Rev Endocrinol 6, 53–56 (2010). https://doi.org/10.1038/nrendo.2009.224

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.224

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing